Shareholders who were hoping an experienced steel maker (big or small) would be announced as a major investor or project partner (and thereby confirm the merits of KFE's project) will be disappointed by yesterday's announcement. With the feasibility study ready to go it was a major opportunity to bring in real technical and financial horsepower.
I agree with bubsmark's comment about funding being secured. Only the first $2.14m is locked in with the second $2.14m subject to a low price get-out clause and the final $2.5m subject to mutual consent. Depending on how you read the announcement, if the share price collapses prior to an allotment, KFE may be forced to repay the first $2.14m (or subsequent advances) with a premium. It seems like a deal weighted in favour of the investor. But some cash is better than no cash.
If the share price stays well above the 1.8c issue price of the non-renounceable rights issue, perhaps a substantial proportion of the $3.8m target will be raised from existing shareholders. If the share price sags, how many shareholders will take up their rights?
So, of the "UP TO $10.3 MILLION" announced by the board yesterday, how much will actually make it to KFE's bank account?
- Forums
- ASX - By Stock
- M4M
- Ann: Capital Raising of up to $10.3 million
Ann: Capital Raising of up to $10.3 million, page-24
Featured News
Add M4M (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $25.36M |
Open | High | Low | Value | Volume |
0.7¢ | 0.7¢ | 0.7¢ | $22.98K | 3.308M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
18 | 7087667 | 0.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.7¢ | 127151 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
16 | 6887667 | 0.006 |
19 | 17530018 | 0.005 |
8 | 7174023 | 0.004 |
6 | 8747011 | 0.003 |
11 | 13735339 | 0.002 |
Price($) | Vol. | No. |
---|---|---|
0.007 | 127151 | 1 |
0.008 | 4803271 | 10 |
0.009 | 4756553 | 12 |
0.010 | 4122000 | 5 |
0.011 | 2541111 | 8 |
Last trade - 14.52pm 15/11/2024 (20 minute delay) ? |
Featured News
M4M (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online